Are Drug-Eluting Stents the Preferred Treatment for Multivessel Coronary Artery Disease?

This publication has 23 references indexed in Scilit:

• Drug‐eluting stent task force: Final report and recommendations of the working committees on cost‐effectiveness/economics, access to care, and medicolegal issues
  Catheterization and Cardiovascular Interventions, 2004
• Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
  New England Journal of Medicine, 2003
• Cost-effectiveness of sirolimus drug-eluting stents for the treatment of complex coronary stenoses: Results from the randomized SIRIUS trial
  Journal of the American College of Cardiology, 2003
• TAXUS I
  Circulation, 2003
• A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
  New England Journal of Medicine, 2002
• Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
  New England Journal of Medicine, 1996
• Three-year follow-up of the argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI)
  Journal of the American College of Cardiology, 1996
• A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery
  New England Journal of Medicine, 1994
• Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial
  The Lancet, 1993
• Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac Events
  New England Journal of Medicine, 1986